Tag Archives: Mylan Pharmaceuticals

Generic Xanax Recall Issued Due To Foreign Substance That May Cause Infections

October 28, 2019 By: Russell Maas
Mylan Valsartan Recall Expanded As More Lots Found To Be Contaminated With NDEA

December 06, 2018 By: Irvin Jackson
Valsartan Recall Issued For Mylan Products Contaminated With NDEA

November 26, 2018 By: Irvin Jackson
EpiPen Problems Lead to Recall Expansion for Products Sold In U.S.

April 03, 2017 By: Russell Maas
EpiPen Recall Issued Outside U.S., Due to Risk Emergency Allergy Drug May Not Work

March 24, 2017 By: Russell Maas
Mylan Gets Warning Letter Over Cancer Drug Recalls

August 20, 2015 By: Irvin Jackson
FDA Probes Generic Toprol XL Effectiveness Following Complaints

May 08, 2014 By: Irvin Jackson
Actos Risks Cause Consumer Reports To Urge Diabetics to Avoid Drug

August 27, 2012 By: Irvin Jackson
Generic Actos Approved Amid Lawsuits Over Bladder Cancer Warnings

August 20, 2012 By: Irvin Jackson
Watson Fentanyl Patch Lawsuits Consolidated in MDL

August 10, 2012 By: Austin Kirk

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 5 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted 6 days ago)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

Change Healthcare Lawsuit Filed Over Release of Sensitive Health Information in Data Breach (Posted 7 days ago)

Pennsylvania woman claims that Change Healthcare failed to adequately protect patient health information from hackers, leaving her and others vulnerable to fraud, identity theft and other damages.

Tag Archives: Mylan Pharmaceuticals

Generic Xanax Recall Issued Due To Foreign Substance That May Cause Infections

Mylan Valsartan Recall Expanded As More Lots Found To Be Contaminated With NDEA

Valsartan Recall Issued For Mylan Products Contaminated With NDEA

EpiPen Problems Lead to Recall Expansion for Products Sold In U.S.

EpiPen Recall Issued Outside U.S., Due to Risk Emergency Allergy Drug May Not Work

Mylan Gets Warning Letter Over Cancer Drug Recalls

FDA Probes Generic Toprol XL Effectiveness Following Complaints

Actos Risks Cause Consumer Reports To Urge Diabetics to Avoid Drug

Generic Actos Approved Amid Lawsuits Over Bladder Cancer Warnings

Watson Fentanyl Patch Lawsuits Consolidated in MDL

More Top Stories

Review A Case